Quality Regulations: Unterschied zwischen den Versionen
K |
|||
| Zeile 32: | Zeile 32: | ||
=== Requirements Health Canada === | === Requirements Health Canada === | ||
Application requirements for cannabis cultivation, processing and medical sales licences | Application requirements for cannabis cultivation, processing and medical sales licences | ||
| + | |||
| + | == United Kingdom (UK) == | ||
| + | MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials' | ||
| + | |||
| + | [https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance] | ||
Version vom 18. Oktober 2021, 14:00 Uhr
Inhaltsverzeichnis
Scope
Regulations for Cultivation & Collection
WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)
Regulations for Processing, Packaging and Storage
Requirements Health Canada
Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.
GAP Canada Version (current Version 9.0 – April 1, 2021) A revision is usually done in February each year.
Health Canada; Good Manufacturing Practices (GUI-0001); July 1, 2020
European Union
Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products
Application requirements for cannabis cultivation, processing and medical sales licences
Requirements Health Canada
Application requirements for cannabis cultivation, processing and medical sales licences
United Kingdom (UK)
MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'